Clinical Trial: A Phase II Study of SHR-8068 Injection in Combination With Anti-tumor Therapies in Colorectal Cancer

U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07071714) titled 'A Phase II Study of SHR-8068 Injection in Combination With Anti-tumor Therapies in Colorectal Cancer' on July 08.

Brief Summary: The study is being conducted to evaluate the safety, tolerability and efficacy of SHR-8068 injection in combination with anti-tumor therapies in subjects with colorectal cancer.

Study Start Date: July, 2025

Study Type: INTERVENTIONAL

Condition: Colorectal Cancer

Intervention: DRUG: SHR-8068 Injection

SHR-8068 injection.

DRUG: Adebrelimab Injection

Adebrelimab injection.

DRUG: Bevacizumab Injection

Bevacizumab injection.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Suzhou Suncadia Biopharmac...